Solitary pulmonary nodules: consequences for patient quality of life

[1]  F. Guillemin,et al.  Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France , 2009, BMC Cancer.

[2]  P. Dagnelie,et al.  Determinants of overall quality of life in preterminal cancer patients , 2008, International journal of cancer.

[3]  F. Guillemin,et al.  Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts , 2008, BMC Cancer.

[4]  A. Brunelli,et al.  Quality of life before and after major lung resection for lung cancer: a prospective follow-up analysis. , 2007, The Annals of thoracic surgery.

[5]  Catherine Beigelman-Aubry,et al.  Management of an incidentally discovered pulmonary nodule , 2007, European Radiology.

[6]  G. Giaccone,et al.  Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  A. Bernard,et al.  Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule , 2005, The European Journal of Health Economics.

[8]  C. Perrotin,et al.  Rsultats de la TEP [ 18F]-FDG dans la stadification propratoire des tumeurs pulmonaires , 2005 .

[9]  R. V. Wijk.  Assessment of quality of life: advantages and pitfalls , 2005 .

[10]  A. Brédart,et al.  Évaluation de la qualité de vie en oncologie: I—Définitions et objectifs , 2005 .

[11]  D. Ost,et al.  Management strategies for the solitary pulmonary nodule , 2004, Current opinion in pulmonary medicine.

[12]  J. Ware,et al.  Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project , 2004, Quality of Life Research.

[13]  J. Vernejoux,et al.  Quality of life in lung cancer: does disclosure of the diagnosis have an impact? , 2004, Lung cancer.

[14]  Ali Montazeri,et al.  How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer , 2003, Quality of Life Research.

[15]  G. Silvestri,et al.  What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. , 2002, Chest.

[16]  J. Cooper.  Management of the solitary pulmonary nodule: directed resection. , 2002, Seminars in thoracic and cardiovascular surgery.

[17]  R. Hays,et al.  Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores , 2002 .

[18]  M. Sprangers.  Quality-of-Life Assessment in Oncology , 2002, Acta oncologica.

[19]  J. Schiller,et al.  Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer , 2001, Oncology.

[20]  Ronette L. Kolotkin,et al.  PQP3: DEFINING CLINICALLY MEANINGFUL CHANGE IN HEALTH-RELATED QUALITY OF LIFE , 2001 .

[21]  Ali Montazeri,et al.  Quality of life in lung cancer patients: as an important prognostic factor. , 2001, Lung cancer.

[22]  N. Aaronson,et al.  The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  D. Sugarbaker,et al.  Management of the solitary pulmonary nodule: role of thoracoscopy in diagnosis and therapy. , 1999, Chest.

[24]  Ali Montazeri,et al.  Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. , 1998, Chest.

[25]  G. Lillington,et al.  Management of solitary pulmonary nodules. How to decide when resection is required. , 1997, Postgraduate medicine.

[26]  M. King.  The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 , 1996, Quality of Life Research.

[27]  D. Simonson,et al.  Assessment of quality-of-life outcomes. , 1996, The New England journal of medicine.

[28]  C. Sherbourne,et al.  Erratum to The MOS 36-item short form health survey (SF-36): I. Conceptual framework , 1992, PharmacoEconomics.

[29]  J. E. Brazier,et al.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care. , 1992, BMJ.

[30]  G. Lillington,et al.  Management of solitary pulmonary nodules. , 1991, Disease-a-month : DM.

[31]  D. Gracey,et al.  The management and evaluation of the solitary pulmonary nodule. , 1974, Chest.

[32]  T. Molina,et al.  [Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumors]. , 2005, Revue des maladies respiratoires.

[33]  A. Brédart,et al.  Quality of life assessment in oncology: I - Definitions and objectives , 2005 .

[34]  Whoqol Group,et al.  Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL) , 2004, Quality of Life Research.

[35]  Ella A Kazerooni,et al.  The solitary pulmonary nodule. , 2003, Chest.

[36]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[37]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[38]  M. Meziane,et al.  TNM staging of lung cancer: a quick reference chart. , 1999, Chest.

[39]  D. Simonson,et al.  ASSESSMENT OF QUALITY-OFLIFE OUTCOMES , 1996 .

[40]  Philippe Coiffet,et al.  Definitions and objectives , 1983 .